Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Acta Cir Bras ; 32(3): 182-193, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28403342

RESUMO

PURPOSE:: To measure the tissue sulfomucin and sialomucin content of the colon mucosa without fecal flow, subjected to intervention with curcumin, and the influence of the concentration used and the intervention time. METHODS:: Thirty-six rats were subjected to proximal right colostomy and distal mucous fistula. They were divided into two groups according to whether sacrifice was performed two or four weeks after the intervention. Each group was divided into three subgroups according to the enema applied daily: saline alone; curcumin at 50 mg/kg/day or curcumin at 200 mg/kg/day. Acid mucins were diagnosed using the Alcian blue technique. The mucin content was quantified by means of computer-assisted image analysis. The significance level of 5% was used throughout (p < 0.05). RESULTS:: There were dose-related increases in the quantities of sulfomucins in the animals subjected to interventions with curcumin, both after two weeks (p < 0.00001) and after four weeks (p < 0.00001). There were increases in sialomucin quantity that were concentration-related (p < 0.00001) and time-related (p < 0.00001). CONCLUSION:: Curcumin enemas increase the quantity of acid mucins in the intestinal flow in the excluded colon, with dose and time dependency.


Assuntos
Colo/química , Colo/efeitos dos fármacos , Mucosa Intestinal/química , Mucosa Intestinal/efeitos dos fármacos , Mucinas/análise , Extratos Vegetais/administração & dosagem , Sialomucinas/análise , Animais , Colite/tratamento farmacológico , Colite/patologia , Colo/patologia , Colostomia , Curcuma , Enema/métodos , Fezes , Trânsito Gastrointestinal/efeitos dos fármacos , Processamento de Imagem Assistida por Computador , Mucosa Intestinal/patologia , Masculino , Mucinas/efeitos dos fármacos , Óleos de Plantas/administração & dosagem , Ratos Wistar , Valores de Referência , Reprodutibilidade dos Testes , Sialomucinas/efeitos dos fármacos , Fatores de Tempo , Resultado do Tratamento
2.
Acta cir. bras ; 32(3): 182-193, Mar. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-837695

RESUMO

Abstract Purpose: To measure the tissue sulfomucin and sialomucin content of the colon mucosa without fecal flow, subjected to intervention with curcumin, and the influence of the concentration used and the intervention time. Methods: Thirty-six rats were subjected to proximal right colostomy and distal mucous fistula. They were divided into two groups according to whether sacrifice was performed two or four weeks after the intervention. Each group was divided into three subgroups according to the enema applied daily: saline alone; curcumin at 50 mg/kg/day or curcumin at 200 mg/kg/day. Acid mucins were diagnosed using the Alcian blue technique. The mucin content was quantified by means of computer-assisted image analysis. The significance level of 5% was used throughout (p < 0.05). Results: There were dose-related increases in the quantities of sulfomucins in the animals subjected to interventions with curcumin, both after two weeks (p < 0.00001) and after four weeks (p < 0.00001). There were increases in sialomucin quantity that were concentration-related (p < 0.00001) and time-related (p < 0.00001). Conclusion: Curcumin enemas increase the quantity of acid mucins in the intestinal flow in the excluded colon, with dose and time dependency.


Assuntos
Animais , Masculino , Extratos Vegetais/administração & dosagem , Colo/efeitos dos fármacos , Colo/química , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/química , Mucinas/análise , Valores de Referência , Fatores de Tempo , Processamento de Imagem Assistida por Computador , Óleos de Plantas/administração & dosagem , Trânsito Gastrointestinal/efeitos dos fármacos , Colostomia , Reprodutibilidade dos Testes , Ratos Wistar , Colite/patologia , Colite/tratamento farmacológico , Colo/patologia , Curcuma , Enema/métodos , Sialomucinas/efeitos dos fármacos , Fezes , Mucosa Intestinal/patologia , Mucinas/efeitos dos fármacos
3.
Blood ; 110(2): 509-18, 2007 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-17403918

RESUMO

Epo's erythropoietic capacity is ascribed largely to its antiapoptotic actions. In part via gene profiling of bone marrow erythroblasts, Epo is now shown to selectively down-modulate the adhesion/migration factors chemokine receptor-4 (Cxcr4) and integrin alpha-4 (Itga4) and to up-modulate growth differentiation factor-3 (Gdf3), oncostatin-M (OncoM), and podocalyxin like-1 (PODXL). For PODXL, Epo dose-dependent expression of this CD34-related sialomucin was discovered in Kit(+)CD71(high) proerythroblasts and was sustained at subsequent Kit(-)CD71(high) and Ter119(+) stages. In vivo, Epo markedly induced PODXL expression in these progenitors and in marrow-resident reticulocytes. This was further associated with a rapid release of PODXL(+) reticulocytes to blood. As studied in erythroblasts expressing minimal Epo receptor (EpoR) alleles, efficient PODXL induction proved dependence on an EpoR-PY343 Stat5 binding site. Moreover, in mice expressing an EpoR-HM F343 allele, compromised Epo-induced PODXL expression correlated with abnormal anucleated red cell representation in marrow. By modulating this select set of cell-surface adhesion molecules and chemokines, Epo is proposed to mobilize erythroblasts from a hypothesized stromal niche and possibly promote reticulocyte egress to blood.


Assuntos
Eritroblastos/fisiologia , Eritropoetina/farmacologia , Receptores da Eritropoetina/genética , Sialoglicoproteínas/genética , Animais , Apoptose/efeitos dos fármacos , Células da Medula Óssea/citologia , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/fisiologia , Núcleo Celular/fisiologia , Eritroblastos/efeitos dos fármacos , Citometria de Fluxo , Perfilação da Expressão Gênica , Camundongos , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sialoglicoproteínas/efeitos dos fármacos , Sialomucinas/efeitos dos fármacos , Sialomucinas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...